Current and future implications of basic and translational research on amyloid-β peptide production and removal pathways

Molecular and Cellular Neurosciences
C BohmPeter St George-Hyslop

Abstract

Inherited variants in multiple different genes are associated with increased risk for Alzheimer's disease (AD). In many of these genes, the inherited variants alter some aspect of the production or clearance of the neurotoxic amyloid β-peptide (Aβ). Thus missense, splice site or duplication mutants in the presenilin 1 (PS1), presenilin 2 (PS2) or the amyloid precursor protein (APP) genes, which alter the levels or shift the balance of Aβ produced, are associated with rare, highly penetrant autosomal dominant forms of Familial Alzheimer's Disease (FAD). Similarly, the more prevalent late-onset forms of AD are associated with both coding and non-coding variants in genes such as SORL1, PICALM and ABCA7 that affect the production and clearance of Aβ. This review summarises some of the recent molecular and structural work on the role of these genes and the proteins coded by them in the biology of Aβ. We also briefly outline how the emerging knowledge about the pathways involved in Aβ generation and clearance can be potentially targeted therapeutically. This article is part of Special Issue entitled "Neuronal Protein".

References

Jun 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·C L MastersK Beyreuther
May 1, 1995·Neurobiology of Aging·D W DicksonP Davies
Feb 24, 1995·The Journal of Biological Chemistry·A LaiI S Trowbridge
Nov 3, 1998·Lancet·C F LippaP St George-Hyslop
Nov 26, 1998·The Journal of Biological Chemistry·W Q QiuD J Selkoe
Apr 8, 2003·Nature Cell Biology·Dieter EdbauerChristian Haass
Aug 11, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Michel Goedert
Sep 23, 2006·Science·Michael WillemChristian Haass
Jan 16, 2007·Nature Genetics·Ekaterina RogaevaPeter St George-Hyslop
Jun 20, 2007·Nature Cell Biology·Doo Yeon KimDora M Kovacs
Jul 22, 2008·Lancet·Peter H St George-Hyslop, John C Morris
Mar 17, 2010·Neuromolecular Medicine·Vivian W ChowMarc Gleichmann
Jun 10, 2010·Nature Reviews. Neurology·Michal Schwartz, Ravid Shechter
Sep 11, 2010·Science·Keith A VosselLennart Mucke
Jun 21, 2011·Nature Genetics·Günter U HöglingerGerard D Schellenberg
Sep 16, 2011·Neurology·S SallowayUNKNOWN ELND005-AD201 Investigators
Oct 12, 2011·Archives of Neurology·Susanne OstrowitzkiLuca Santarelli
Mar 20, 2012·Cell·Yadong Huang, Lennart Mucke
May 4, 2012·Cold Spring Harbor Perspectives in Medicine·Christian HaassSangram Sisodia
Jun 8, 2012·Neurobiology of Aging·Badri N VardarajanLindsay A Farrer
Oct 12, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Rachel F LaneSam Gandy
Nov 14, 2012·Journal of Cell Science·Matthew N J Seaman
Apr 16, 2013·The Journal of Biological Chemistry·Taisuke Tomita, Takeshi Iwatsubo

❮ Previous
Next ❯

Citations

Jan 30, 2016·Alzheimer's Research & Therapy·Jeffrey L CummingsJames Bena
Feb 16, 2016·Biochemistry. Biokhimii︠a︡·O G TatarnikovaN V Bobkova
Oct 18, 2015·Archives of Biochemistry and Biophysics·Laia Montoliu-Gaya, Sandra Villegas
Mar 15, 2016·Scientific Reports·Joanna L RichensPaul O'Shea
Mar 10, 2015·Molecular and Cellular Neurosciences·George K Tofaris, Anthony H V Schapira
Oct 22, 2016·Journal of Neuropathology and Experimental Neurology·Stephanie L AdamsIvana Delalle
Jul 1, 2015·Trends in Molecular Medicine·Deirdre M O'Connor, Nicholas M Boulis
May 18, 2016·Organic & Biomolecular Chemistry·Chao ZuoJi-Shen Zheng
Nov 5, 2017·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Alex J Smith, Alan S Verkman
Jul 9, 2016·Biological Chemistry·Kunihiko Kanatsu, Taisuke Tomita
Nov 4, 2015·Journal of Alzheimer's Disease : JAD·Adriana SavastanoThomas A Bayer
Nov 6, 2015·Frontiers in Aging Neuroscience·Pasquale GallinaBerardino Porfirio
Mar 3, 2019·International Journal of Molecular Sciences·Michał WicińskiKatarzyna Pawlak-Osińska
Sep 16, 2020·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·M B Nuvakhova, S A Rachin
Nov 25, 2016·Experimental and Therapeutic Medicine·Xiaohui WangYang Li
May 28, 2017·Journal of Alzheimer's Disease : JAD·Norimichi NakamuraJun-Ichi Kira
Sep 9, 2018·Interdisciplinary Sciences, Computational Life Sciences·Dhiraj Kumar, Pravir Kumar
Jan 11, 2019·Medicinal Research Reviews·Nalini SchaduangratChanin Nantasenamat
Apr 10, 2016·The Journal of Biological Chemistry·Xavier Meckler, Frédéric Checler
Mar 18, 2017·Journal of Alzheimer's Disease : JAD·Gisela Esquerda-CanalsSandra Villegas
Jun 16, 2019·Cellular and Molecular Life Sciences : CMLS·Franka ScharfenbergChristoph Becker-Pauly
Jun 20, 2020·Journal of the Neurological Sciences·Md Sahab UddinGhulam Md Ashraf
Jul 20, 2020·Ageing Research Reviews·Amalia C BruniCarlo Gabelli
Feb 20, 2020·Molecular Therapy. Nucleic Acids·Ana Teresa Barros-ViegasAna Luísa Cardoso

❮ Previous
Next ❯

Methods Mentioned

BETA
electron microscopy
exome sequencing
BACE
transgenic

Related Concepts

Related Feeds

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: Microglia

Microglia are a type of glial cell found throughout the brain and spinal cord. Microglia have been found to be associated with Alzheimer's disease development and progression. Here are the latest discoveries pertaining to Alzheimer's disease and microglia.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Related Papers

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
Takahisa KanekiyoGuojun Bu
Alzheimer's Research & Therapy
Kristin R WildsmithGary E Landreth
© 2022 Meta ULC. All rights reserved